The German Breast Group – Healing Through Innovation, Competence and Partnership

The German Breast Group (GBG) is the leading breast cancer study group in Germany, conducting clinical trials in the adjuvant, neoadjuvant, preventative and palliative settings. One focus of the GBG is neoadjuvant studies, which have a long and successful history in Germany. The aim of neoadjuvant studies is to improve operability and to gain more information about the tumour itself in terms of the chemotherapy (invivo) as well as regarding the biology in general. However, preventative, palliative and adjuvant studies are also important components of the GBG. This article is an overview of the structure and working practice of the GBG and gives a sample of trials currently being led by the GBG.